This inventor holds 1 USPTO granted patent. Top assignee: Eisai Chemical Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Masato Kodama: Innovator in Cephem Compound Production
Introduction
Masato Kodama is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the production of cephem compounds. His innovative work has implications for the development of antibiotics, which are crucial in modern medicine.
Latest Patents
Kodama holds a patent for a novel process for producing cephem compounds in an aqueous medium. This industrially excellent process is represented by the formula (III) and involves the reaction of a 3-cephem-4-carboxylate with an acid chloride. The resulting cephem compounds are valuable as medicines, especially antibiotics. He has 1 patent related to this innovative process.
Career Highlights
Masato Kodama is associated with Eisai Chemical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical chemistry. His work has not only contributed to the company's portfolio but has also enhanced the understanding of cephem compounds in the scientific community.
Collaborations
Kodama has collaborated with notable colleagues such as Hirofumi Kuroda and Homare Shinohara. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared field of expertise.
Conclusion
Masato Kodama's contributions to the production of cephem compounds highlight his role as a key inventor in the pharmaceutical industry. His innovative processes pave the way for the development of essential antibiotics, showcasing the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile